NRX Pharmaceuticals (NRXP) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.75
-0.52
-0.28
-0.05

Details

Expected EPS
-0.555
Actual EPS
-0.15
Surprise EPS
0.41
Surprise Percent
+72.97%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.15 per share for Q4 2024.

0 Comments

Share your thoughts